CIK 0001396814 · Large accelerated filer
Pacira BioSciences, Inc.
Sign in to watch- Ticker
- PCRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 510619477
- Phone
- 650-242-8052
- Business address
- 2000 SIERRA POINT PARKWAY, SUITE 900, BRISBANE, CA, 94005
- Former names
- Pacira Pharmaceuticals, Inc., PACIRA INC, Blue Acquisition Corp
- 4 Grant or award Chief Administrative Officer acquired 33,700 shares (grant or award)
- 4 Grant or award Chief Operating Officer acquired 33,700 shares (grant or award)
- 4 Shares withheld for taxes Senior Vice President, Finance gave up 159 shares (to pay taxes)
- 4 Grant or award Chief Medical Officer acquired 5,000 shares (grant or award)
- 4 Grant or award Chief Executive Officer acquired 99,520 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market sale Chief Medical Officer sold 509 shares at $34.88 ($17,751)
- 4 Planned sale Senior Vice President, Finance sold 643 shares at $38.91 ($25,019)
- 4 Grant or award Chief Medical Officer acquired 10,950 shares (grant or award)
- 4 Planned sale Chief Administrative Officer sold 6,467 shares at $37.03 ($239,473)
- 4 Grant or award CEO and Chairman acquired 32,700 shares (grant or award)
Page 6 of 35 · 695 filings